Sitemap

EU Expects First COVID Vaccine Application In Coming Days

Scottish Government Seeks Independence Vote In October 2023

Scottish First Minister Nicola Sturgeon said on...

Ambassador Thomas Schieb: Sanctions On Russia Will Help Serbia Progress

German Ambassador to Serbia Thomas Schieb said...

Eu Clinches Deal On Mandatory Gas Storage For Next Winter

European Union negotiators agreed on mandatory gas...

UK, U.S., Japan And Canada To Ban Russia Gold Imports

Britain, the United States, Japan and Canada...

The EIB And Unicredit Promote Socially Inclusive Employment And Entrepreneurship

The European Investment Bank (EIB) and UniCredit Bank Serbia (UniCredit) have officially launched a €30 million credit line aimed...

Hong Kong: Xi Jinping Defends China’s Rule At Handover Anniversary

China's "one country two systems" model of ruling Hong Kong has worked in protecting the city and must continue...

Investments Yet To Convert Into Significant Bilateral Trade

Although trade cooperation between the U.S. and Serbia remains below the level of a billion dollars, the two countries...

New French Investments Expected

The visit of French President Emmanuel Macron to Serbia marked a turning point in the development of economic relations...

EU To Extend Digital Covid Certificate For Travel Until June 2023

As the current EU Digital Covid Certificate rules are set to expire on 30 June, the Committee on Civil...

The European Medicines Agency did not name the company it expects to file the application. However, EU leaders hope a vaccine will be available before the end of the year.

The first application for marketing approval of a COVID-19 vaccine in the European Union should arrive in the next few days, according to the European Medicines Agency (EMA).

The drug watchdog did not identify the drugmaker expected to file, however partners Pfizer and BioNTEch are the most advanced in the regulatory approval process. A total of three drugmakers have published late-stage trial data for their respective coronavirus vaccine candidates, including US firm Moderna, and a British partnership between AstraZeneca and Oxford University.

The Pfizer-BioNTech collaboration has already applied for approval in the US, and the UK has asked its medical regulator to assess the vaccine.

Researchers on the US-German vaccine should enjoy a speedy approval process, as they have been allowed to submit data in real-time to the EMA, without waiting for studies to conclude.

The EMA earlier acknowledged it was trying “to speed up” the evaluation process, but said it was “ensuring the same high regulatory standards for quality, safety and efficacy” as for any other drug.

EMA told the AFP news agency that it could approve the first COVID-19 vaccines by the end of the year. Many European countries, including France, Spain and Italy, have based their immunization plans on that basis.

German Chancellor Angela Merkel told lawmakers Thursday that a vaccine may become available before the end of the year.

In the US, if the Food and Drug Administration (FDA) approves accelarated rollout, vaccination efforts may start as early as mid-December.

Related

US Pharma Firm Moderna Says Its COVID-19 Vaccine Is 94.5% Effective

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker...

Oxford Covid Vaccine Works In All Ages, Trials Suggest

Covid vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups One of the world’s leading Covid-19 experimental vaccines produces an...

Vaccination rollout

In China, medical authorities have already begun immunizing high-risk patients. In Russia, two vaccines have been validated for use before the final phase of clinical trials had started.

The candidates that have passed trials all claim more than 90% effiacy, but their results have not yet been backed up by by publication in peer-reviewed journals, which can usually take months.

Price and logistics will also factor in the success of the vaccines. AstraZeneca’s double dose is the cheapest, costing about €2.5 ($3) per dose and requires just a normal fridge temperature. Moderna’s vaccine must be kept at -20 degrees Celsius (-4 Farenheit), while Pfizer’s must be kept at -70C (-94 Farenheit).

Source:  Deutsche Welle

Related Articles

EU Agrees On Rules To Tame Crypto Market

The European Union has agreed on ground-breaking rules for regulating crypto assets, EU lawmakers said on Thursday, as the rout in bitcoin piles pressure...

Hong Kong: Xi Jinping Defends China’s Rule At Handover Anniversary

China's "one country two systems" model of ruling Hong Kong has worked in protecting the city and must continue long term, says Xi Jinping. The...

French Presidency Of The Council Of The European Union

Europe’s Sovereignty At Heart

As French President Emmanuel Macron spelled out, the French Presidency of the Council of the European Union focused on recovery, strength and a sense...

EU To Extend Digital Covid Certificate For Travel Until June 2023

As the current EU Digital Covid Certificate rules are set to expire on 30 June, the Committee on Civil Liberties, Justice and Home Affairs...

Iran Applies To Join BRICS Club

Iran, which holds the world's second largest gas reserves, has applied to join the BRICS group of Brazil, Russia, India, China and South Africa...

Eu Clinches Deal On Mandatory Gas Storage For Next Winter

European Union negotiators agreed on mandatory gas storage obligations for EU countries, aiming for the the bloc’s storages to be at least 85% full...

EU Preparing Investment Plan For Western Balkans Worth 30 Billion Euros

The leaders of the European Union and the Western Balkans held a four-hour discussion in Brussels on the challenges of the current geostrategic situation...

Alessandra Moretti Is The New Chair Of EP Delegation To Serbia

The European Parliament (EP) has elected Alessandra Moretti, a member of the Socialists and Democrats from Italy, as chair of the EU-Serbia Stabilization and...